Search results
Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses...
Simply Wall St. via Yahoo Finance· 2 years agoSorrento Therapeutics, Inc. (NASDAQ:SRNE) shareholders should be happy to see the share price up 22%...
Sorrento (SRNE) Gets FDA Fast Track Tag for Back Pain Product
Zacks via Yahoo Finance· 2 years agoSorrento Therapeutics’ SRNE subsidiary Scilex Holding Company recently received Fast Track...